Skip to main content
Glama

Kegg

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.3/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already provide readOnly/openWorld/idempotent hints, yet the description adds substantial behavior beyond them: parallel fan-out across nine sources, GDELT-to-GNews fallback, `sources_used`/`sources_failed` semantics, 'an empty section is a real "no data", not a bug,' private-company resolved:false handling with a notes line, and the fda_products expected-empty caveat. No statement contradicts the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Well front-loaded: example queries and the core purpose open the description. However, it is one unbroken, dense paragraph of over 200 words mixing source enumeration, return-field definitions, no-data semantics, and input-shape guidance, with the input-shape portion partially repeating the schema. Bullet separation would substantially improve scannability.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden of return-value disclosure — and it pays it: every return section is enumerated (cik, company_name, recent_filings with URI format and 5-item cap, fundamentals fields, patents, federal_contracts, fda_products, hiring, news, LEI) plus failure semantics and name-resolution behavior. Remaining gaps such as invalid-ticker handling are minor against this coverage.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3 and the schema carries the semantic load: both parameters have descriptions, including the interchangeability of type values and the ticker/CIK/name forms for value. The description adds concrete value examples ('AAPL', '0000320193', 'Moderna') and the resolved_from/resolved_to note, but these are modest enhancements, not essential compensations.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Opens with seven concrete user-query examples, then states the core function: 'full cross-source profile of a US public company in ONE parallel call.' The verb-resource-scope combination ('profile' + 'US public company' + 'cross-source') clearly distinguishes it from siblings like resolve_entity, compare_entities, and deep_research, none of which build a single holistic multi-source profile.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly guides the agent: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view,' naming the alternative behavior and the triggering condition. The example query patterns further operationalize when to invoke it. It does not, however, state exclusions for overlapping siblings such as compare_entities or deep_research.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Kegg toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation3/5

Most tools have clearly described distinct purposes, but several overlap: ask_pipeworx and ask_pipeworx_beta are explicitly identical right now, and ask_pipeworx_grounded, deep_research, discover_tools, and suggest_questions all occupy neighboring query/discovery territory. The Polymarket and memory tool families, by contrast, are well differentiated.

Naming Consistency3/5

All names are snake_case and readable, but the set mixes verb-first names (ask_pipeworx, compare_entities, resolve_entity, validate_claim) with noun-phrase names (entity_profile, bet_research, recent_alerts, polymarket_arbitrage) and brand prefixes (pipeworx_*, polymarket_*). There is no consistent verb_noun pattern across the toolkit.

Tool Count2/5

34 tools is well beyond the heavy range, and the count is especially inappropriate because the server is named Kegg but only find, get_entry, and list_database relate to KEGG bioinformatics. The remaining 31 tools span unrelated domains (generic data research, prediction markets, memory, subscriptions, AI visibility, npm scanning), making the scope feel like several products merged into one.

Completeness2/5

As a KEGG server, the surface is severely thin: three read-only tools with no pathway mapping, sequence search, or cross-reference utilities. The Pipeworx research and Polymarket betting subsystems are more complete, but their presence under a Kegg server makes the overall surface incoherent rather than complete.

Resources